GGrantIndex
← Search

Shared Resource Management

$41,345P30FY2023CANIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications, trials & patents

Paper 39499645Paper 39392861Paper 39378878Paper 39332920Paper 39259591Paper 39207105Paper 39193906Paper 39127153Paper 39081315Paper 39028768Paper 39025270Paper 38902475Paper 38898085Paper 38896451Paper 38863869Paper 38778498Paper 38753503Paper 38717519Paper 38700353Paper 38699331Paper 38679747Paper 38657656Paper 38645169Paper 38643166Paper 38608634Paper 38597673Paper 38571760Paper 38565851Paper 38559037Paper 38477945Paper 38463959Paper 38458178Paper 38436133Paper 38405931Paper 38402617Paper 38400039Paper 38387080Paper 38352476Paper 38334805Trial NCT05016622Trial NCT04514484Trial NCT04401670Trial NCT03648983Trial NCT02774291Trial NCT02649569Trial NCT02578888Trial NCT02575872Trial NCT02527304Trial NCT02507076Trial NCT02382419Trial NCT02277561Trial NCT02112552Trial NCT02073968Trial NCT02038153Trial NCT02009436Trial NCT01958580Trial NCT01939210Trial NCT01899326Trial NCT01899261Trial NCT01897454Trial NCT01897441Trial NCT01857271Trial NCT01772420Trial NCT01697293Trial NCT01695941Trial NCT01605032Trial NCT01408160Trial NCT01367301Trial NCT01351909Trial NCT01319539Trial NCT01231906Trial NCT01145430Trial NCT01142401Trial NCT01061606Trial NCT01041027Trial NCT01001910Trial NCT00950365Trial NCT00470301Trial NCT00450944Trial NCT00437034Trial NCT00392353Trial NCT00324740Trial NCT00182767Trial NCT00179348Trial NCT00121251Trial NCT00096317Trial NCT00066638Trial NCT00057863Trial NCT00055692Trial NCT00030706Trial NCT00019474Trial NCT00004864Trial NCT00004863Trial NCT00003867Trial NCT00002461Patent 9671391Patent 7709613Patent 6821725Patent 6013468Patent 5876979

Abstract

Program Director/Principal Investigator (Last, First, Middle): Chu, Edward SHARED RESOURCE MANAGEMENT - PROJECT SUMMARY/ABSTRACT The Montefiore Einstein Cancer Center (MECC) Shared Resources (SRs) support the entire range of cancer- focused basic, clinical, translational, and population sciences and provide access to MECC members to state- of-the-art methodology and instrumentation, high-level expertise and instruction, and cost-effective sources of research support. MECC SRs are closely aligned with the scientific strategic priorities of the MECC. They greatly facilitate research investigating cancer biology at the molecular, cellular and organismic level, including the biology and signaling that are directly relevant to the unique Bronx patient population served by MECC; development and evaluation of new cancer therapeutics; and identification of genetic, epidemiological, behavioral, and social determinants of health causality in our diverse catchment area population. Additional SRs promote the acquisition, storage, and analysis of patient sample and the management and coordination of clinical trials within the MECC catchment area for ongoing cancer-focused research. MECC SRs are managed at multiple levels to ensure a high quality of services, responsiveness to MECC members, and alignment with the MECC Strategic Plan. Management tools and strategies include input to the SR directors from expert User Advisory Committees and survey data from MECC membership; monitoring of SR performance by the Shared Resource Oversight Committee (SROC), which is chaired by the Associate Director for SR; monthly Research Leadership Council (RLC) meetings with all MECC SR Directors and Program Leaders; meetings with the Excellence in Career Enrichment Leadership (ExCEL) Committee, composed of junior and mid-level faculty members; and direct reporting by the Associate Director for SR to the Senior Leadership Team of the MECC. MECC SRs are managed in partnership with the Albert Einstein College of Medicine (Einstein) such that MECC contributions are used to leverage substantial institutional support. As such, oversight of SR finances is conducted on a quarterly basis by the Associate Director for SR and the Deputy Director for Administration, in collaboration with senior administrative officials from the Dean’s office. Leveraging Einstein support has greatly facilitated the expansion of SR services and acquisition of innovative new instrumentation in multiple SRs. Moreover, these quarterly meetings with the Dean’s office ensure that MECC priorities are recognized. Our active engagement with MECC membership through user surveys, User Advisory Committees, Research Leadership Council, and ExCEL Committee provide critical guidance in shaping new initiatives within our MECC SR program. Future initiatives focus on developing and implementing innovative new technologies, services, and expansion of critical SR personnel; enhancing coordination between MECC SRs; expanding education and training initiatives; and expanding administrative infrastructure and support. OMB No. 0925-0001/0002 (Rev. 03/2020 Approved Through 02/28/2023) Page

View original record on NIH RePORTER →